Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FL104
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $133,597
Award facts
- Contract value 100% obligated
- $133,596.63 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $133,596.63 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside contract was awarded competitively and represents a task order under the prime contractor's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is Conshohocken, Pennsylvania, which serves as the corporate headquarters for Amerisourcebergen Drug Corp.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (Doing Business As Amerisourcebergen), is a major pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive range of medical products to federal military and veteran healthcare systems. The company's federal contract portfolio encompasses prescription medications, generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains including diabetes treatments, neurological medications, pain management pharmaceuticals, and antibiotics. The DLA Troop Support Medical IDC serves as a global pharmaceutical support vehicle enabling Amerisourcebergen to supply medical commodities to customers including the Defense Health Agency and U.S. Coast Guard, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts potentially involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DU26FL104?
SPE2DU26FL104 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DU26FL104 worth?
The government has obligated $133,597 on SPE2DU26FL104.
Is contract SPE2DU26FL104 an order under another contract?
Yes. SPE2DU26FL104 is a delivery order under SPE2DU25D4118, an indefinite delivery contract.
Was contract SPE2DU26FL104 competed?
The extent of competition for SPE2DU26FL104 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award